BioRestorative Therapies (BRTX) Projected to Post Earnings on Friday

BioRestorative Therapies (NASDAQ:BRTX) is expected to be issuing its quarterly earnings data before the market opens on Friday, April 4th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Stock Performance

BRTX stock opened at $1.83 on Friday. The company has a market capitalization of $12.66 million, a price-to-earnings ratio of -1.20 and a beta of 64.37. The business’s 50 day moving average price is $1.97 and its two-hundred day moving average price is $1.72. BioRestorative Therapies has a fifty-two week low of $1.03 and a fifty-two week high of $2.55.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.